US Supreme Court’s EPA Ruling Expected To Have Limited Impact On FDA Regulations
Executive Summary
Court restricts EPA’s ability to regulate greenhouse gas emissions saying agency must have “clear congressional authorization” to address “major questions.” Decision is not likely to pose a problem for the FDA unless it were to regulate something new, attorneys say.
You may also be interested in...
Supreme Court Rules Narrowly Against Medicare Payments Cuts To 340B Hospitals
The decision doesn’t directly impact manufacturers or the 340B discounts they are required to provide – and does not address the potentially much broader regulatory issue of whether the Supreme Court’s so-called Chevron doctrine should be changed.
Payors Take Lead From FTC In Suing BI Over Its Orange Book Patent Listings For Inhalers
Class action complaint alleges Boehringer Ingelheim engaged in a ‘Respimat Orange Book scheme’ to thwart generic competition for Combivent Respimat and Spiriva Respimat that cost payors millions, if not billions, in overcharges.
IRA Litigation: NJ Judge Looks For Own Path In Evaluating Medicare Price Negotiation Program
During oral argument in four cases challenging the IRA, Judge Zahid Quraishi suggested he may find that Medicare participation is voluntary but takings claim would still need to be considered. On question of whether the program is hurting innovation, Quraishi seemed skeptical.